Atherosclerosis risk factors related to hemodialysis duration and erythropoietin therapy

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 6, 2001, Pages 484-486

  Dejanova, B ^a   Filipce, V ^a   Dejanov, P ^a   Sikole, A ^a   Grozdanovski, R ^a   Maleska, V ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Atherosclerosis; Erythropoietin; Hemodialysis; Lipids

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; ERYTHROPOIETIN; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMPLICATION; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; LIPID PEROXIDATION; LIPIDS; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES;

EID: 0034925561     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.079     Document Type: Article

References (13)

1. Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis
2. Atherosclerosis: What is it and why does it occur?
3. Antioxidants and atherosclerotic heart disease
4. Lipids, diabetes, and vascular disease: The time to act
5. Atherosclerosis as a post-prandial disease
6. Lipid peroxides and human diseases
7. High density lipoprotein metabolism
8. Oxidative stress and vascular injury - Relevant for atherogenesis in uraemic patients?
9. Lipid profile in hemodialysis patients treated with recombinant human erythropoietin
10. Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rhEPO treatment
11. Lipid and apolipoprotein patterns during erythropoietin therapy: Roles of erythropoietin, route of administration, and diet
12. Lipoprotein (a) in renal disease
13. Lipoprotein (a) as a risk factor for ischemic heart diseas: Metaanalysis of propective studies